Remove Events Remove Family Practice Remove Hospital Remove Patients
article thumbnail

Fecal Microbiota Transplantation Could Be First-Line Therapy for C. Difficile

Physician's Weekly

from Oslo University Hospital in Norway, and colleagues examined the efficacy and safety of FMT in primary CDI in a randomized, open-label, noninferiority trial. percent of 51 patients receiving FMT versus 61.2 percent of 49 patients receiving vancomycin (difference, 5.4 Frederik Emil Juul, M.D., percentage points; 95.2

article thumbnail

FDA Approves Polypill Widaplik for Hypertension

Physician's Weekly

The combination pill is the first and only FDA-approved triple combination medication for use as an initial therapy in patients who will likely need multiple drugs to achieve their ideal blood pressure numbers. The most common adverse event reported in patients treated with Widaplik was symptomatic low blood pressure.